Artificial Intelligence (AI) is revolutionizing the pharmaceutical industry by transforming the drug discovery process. Traditional drug development is time-consuming, often taking more than a decade and costing billions of dollars. AI is changing this landscape by accelerating research, improving accuracy, and reducing costs.
AI technologies such as machine learning, deep learning, and predictive analytics enable researchers to analyze vast biological datasets efficiently. These tools help identify potential drug candidates, optimize molecules, and predict drug interactions with higher precision.
The global AI in drug discovery market is witnessing rapid growth. The market is expected to grow significantly due to increasing demand for faster and cost-effective drug development solutions. Reports indicate that the market could grow from around USD 2–3 billion to over USD 13 billion by the early 2030s, driven by strong adoption across pharmaceutical companies.
Read More:
https://www.stalwartresearchinsights.com/product/ai-in-drug-discovery-industry-outlook-2020-2035
Locked
